AstraZeneca enters co-promotion agreement with Janssen in Japan for innovative prostate cancer treatment
|
11 October 2013 |
AstraZeneca and Merck enter licence agreement for investigational oral WEE1 kinase inhibitor therapy for cancer
|
11 September 2013 |
MedImmune strengthens immune-mediated cancer therapy portfolio with acquisition of Amplimmune
|
26 August 2013 |
AstraZeneca PLC second quarter and half year results 2013
|
01 August 2013 |
AstraZeneca and Bristol-Myers Squibb resubmit dapagliflozin New Drug Application
|
25 July 2013 |
AstraZeneca collaborates with Cambridge medical research institutions to advance cancer research
|
09 July 2013 |
AstraZeneca selects location for new global R&D centre and corporate headquarters
|
19 June 2013 |
MedImmune, AstraZeneca's biologics arm, and NGM Biopharmaceuticals announce agreement to discover and develop therapies for diabetes and obesity
|
17 June 2013 |
AstraZeneca to acquire Pearl Therapeutics to strengthen respiratory portfolio
|
10 June 2013 |
AstraZeneca to acquire Omthera Pharmaceuticals including NDA-ready novel dyslipidemia treatment to complement cardiovascular portfolio
|
28 May 2013 |